Home Price calculator
Tirzepatide Price Calculator
Pick the dose you expect to maintain. We price every tracked program at that tier, membership fees included.
What you actually pay at your dose
Advertised prices usually quote the 2.5 mg starter tier. Pick the dose you expect to maintain.
Prices verified 2026-08-05 and include any separate membership fee. Dose-scaled programs are modeled across their published range. Confirm your quote in writing before enrolling — how we verify.
How this calculator works
Flat-rate programs return the same figure at every dose. Dose-scaled programs are modeled linearly across their published range, from the entry price at 2.5 mg to the maximum at 15 mg. Brand routes that step at a specific strength — LillyDirect vials move up at 7.5 mg — are modeled as a step rather than a slope.
Membership and platform fees are added automatically. Where a program publishes a prepaid rate, selecting "best prepaid rate" applies it. The twelve-month view multiplies the selected monthly figure by twelve; for the realistic escalation curve (four weeks at 2.5 mg, four weeks at 5 mg, ten months at maintenance) see the right-hand column of the full price grid.
What it cannot tell you
Whether you will be approved. Whether your state is served. What a program will quote you after intake. Prices in this market move, sometimes weekly. Every figure carries the date we last checked it, and we ask you to confirm your own quote in writing before paying — see our verification method.
How this price is stated. All-in monthly price: medication plus any recurring membership or platform fee, at the stated dose tier, before tax and before any prepaid-term discount. Figures here are quoted at 10 mg. Prepaid rates and brand self-pay tiers are shown separately where they apply, never blended into the headline. Verified 2026-08-05. How we verify prices.
Every price on this site carries one of three verification levels, and they are not the same claim. 14 records are verified at source; 9 carry a third-party figure we have not confirmed with the provider; the rest publish no price at all.
- verified at source — Price read from the provider's own site, the manufacturer, or a named editorial source with a stated verification date.
- third-party figure — Price recorded from a third-party review supplied to us, not confirmed against the provider's own published material. Treat as indicative and confirm before enrolling.
- no price published — No figure we could interpret or verify. We publish nothing rather than estimate.
Levels are published per record in the open dataset. Where we verified a figure directly, seven times out of seven the correction changed the number.
| Program | 2.5 mg | 5 mg | 7.5 mg | 10 mg | 12.5 mg | 15 mg | 12-month |
|---|---|---|---|---|---|---|---|
| IVIM Health dose-scaled | $208 | $231 | $255 | $278 | $302 | $325 | $3,219 |
| Oak Longevity flat pricing | $199 | $199 | $199 | $199 | $199 | $199 | $2,388 |
| Mochi Health flat pricing | $278 | $278 | $278 | $278 | $278 | $278 | $3,336 |
| ShedRx dose-scaled | $199 | $229 | $259 | $289 | $319 | $349 | $3,318 |
| NexLife flat pricing | $215 | $215 | $215 | $215 | $215 | $215 | $2,580 |
| bmiMD flat pricing | $233 | $233 | $233 | $233 | $233 | $233 | $2,796 |
| Eden dose-scaled | $348 | $368 | $388 | $408 | $428 | $448 | $4,796 |
| Join Fridays flat pricing | $249 | $249 | $249 | $249 | $249 | $249 | $2,988 |
| Yucca Health flat pricing | $258 | $258 | $258 | $258 | $258 | $258 | $3,096 |
| Direct Meds flat pricing | $280 | $280 | $280 | $280 | $280 | $280 | $3,360 |
| Zealthy flat pricing | $346 | $346 | $346 | $346 | $346 | $346 | $4,152 |
| SkinnyRx flat pricing | $299 | $299 | $299 | $299 | $299 | $299 | $3,588 |
| LillyDirect (Zepbound) dose-scaled | $299 | $299 | $449 | $449 | $449 | $449 | $5,088 |
| MyStart Health flat pricing | $299 | $299 | $299 | $299 | $299 | $299 | $3,588 |
| Gala Health flat pricing | $299 | $299 | $299 | $299 | $299 | $299 | $3,588 |
| Sprout Health flat pricing | $299 | $299 | $299 | $299 | $299 | $299 | $3,588 |
| Willow flat pricing | $299 | $299 | $299 | $299 | $299 | $299 | $3,588 |
| Found flat pricing | $398 | $398 | $398 | $398 | $398 | $398 | $4,776 |
| Strut Health flat pricing | $325 | $325 | $325 | $325 | $325 | $325 | $3,900 |
| TrimRx flat pricing | $349 | $349 | $349 | $349 | $349 | $349 | $4,188 |
| OnlineSemaglutide.org flat pricing | $349 | $349 | $349 | $349 | $349 | $349 | $4,188 |
| MEDVi flat pricing | $399 | $399 | $399 | $399 | $399 | $399 | $4,788 |
| LifeMD flat pricing | $548 | $548 | $548 | $548 | $548 | $548 | $6,576 |
People also ask about tirzepatide price calculator
What is tirzepatide price calculator?
Tirzepatide price calculator is covered in full on this page, with the clinical detail drawn from the tirzepatide prescribing information and the published SURMOUNT and SURPASS trial program, and any price figures drawn from our tracked dataset and dated to their last verification.
Does tirzepatide price calculator apply to compounded tirzepatide as well as Zepbound?
The molecule is the same, so the clinical content applies to both. What differs is regulatory status, dose metering and price: compounded preparations are not FDA-approved, arrive as a multi-dose vial you measure yourself, and cost a fraction of the brand routes.
How much does tirzepatide price calculator cost per month in 2026?
Compounded tirzepatide runs from $133 per month at the entry dose across the 21 compounded programs we track. At a 10 mg maintenance dose the cheapest tracked route is Oak Longevity at $199 per month, or about $2,388 for a first year on the standard escalation. Brand Zepbound through manufacturer self-pay sits well above that and pharmacy retail well above again. Verified 2026-08-05.
Is tirzepatide price calculator FDA-approved?
Brand tirzepatide (Zepbound and Mounjaro) is FDA-approved. Compounded tirzepatide is not: FDA does not approve compounded drugs and does not review them for safety, effectiveness or quality before they are marketed. The active molecule is the same; the regulatory review is not.
Primary sources
Clinical, dosing and regulatory statements on this page rest on the documents below. Links go to the publisher, not to a summary of it. Prices are not sourced here — they carry a verification date instead, and the reason is set out in the source ledger.
- ZEPBOUND (tirzepatide) full prescribing information — DailyMed, US National Library of Medicine. Dose ladder, contraindications, warnings, storage.
- FDA’s concerns with unapproved GLP-1 drugs used for weight loss — US Food and Drug Administration. Compounded GLP-1 risks, API import alert, cold-chain complaints.
- FD&C Act provisions that apply to human drug compounding — US Food and Drug Administration. Why a compounded preparation is lawful without being FDA-approved.
- Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1) — N Engl J Med 2022;387:205-216. Registration NCT04184622. The weight-reduction and adverse-event figures used across this site.
- The full source ledger — every primary source, what it supports, the date we read it, and the claims we deliberately do not source.